{
  "pro-SFTPB": {
    "Type":"Protein",
    "Names": [
        "Pro-surfactant protein B"
    ],
    "Drug_Name(if_FDA_Approved)":"",
    "State_Change":"Normal",
    "Disease":"Non-Small Cell Lung Cancer",
    "Disease_Stage":"Prediction",
    "Critical_Works_ID":"PMC3871515"
  },
  "APOA1": {
    "Type":"Protein",
    "Names": [
        "Apolipoprotein A1"
    ],
    "Drug_Name(if_FDA_Approved)":"",
    "State_Change":"Normal",
    "Disease":"Ovarian Cancer",
    "Disease_Stage":"Early",
    "Critical_Works_ID":"CAN040746"
  },
  "TTHY": {
    "Type":"Protein",
    "Names": [
        "Transthyretin"
    ],
    "Drug_Name(if_FDA_Approved)":"",
    "State_Change":"Truncated",
    "Disease":"Ovarian Cancer",
    "Disease_Stage":"Early",
    "Critical_Works_ID":"CAN040746"
  },
  "ITIH4": {
    "Type":"Protein",
    "Names": [
        "Inter-alpha-trypsin inhibitor heavy chain H4"
    ],
    "Drug_Name(if_FDA_Approved)":"",
    "State_Change":"Cleavage Fragment",
    "Disease":"Ovarian Cancer",
    "Disease_Stage":"Early",
    "Critical_Works_ID":"CAN040746"
  },
  "IL-8": {
    "Type":"Protein",
    "Names": [
        "Interleukin 8"
    ],
    "Drug_Name(if_FDA_Approved)":"",
    "State_Change":"Normal",
    "Disease":"Bladder Cancer",
    "Disease_Stage":"Detection",
    "Critical_Works_ID":"PMC3404900"
  },
  "CA 19-9": {
    "Type":"Protein",
    "Names": [
        "Carbohydrate antigen 19-9"
    ],
    "Drug_Name(if_FDA_Approved)":"",
    "State_Change":"Normal",
    "Disease":"Pancreatic Adenocarcinoma",
    "Disease_Stage":"All",
    "Critical_Works_ID":"PMC4419808"
  },
  "miR-10b": {
    "Type":"microRNA",
    "Names": [
        "microRNA 10b"
    ],
    "Drug_Name(if_FDA_Approved)":"",
    "State_Change":"Normal",
    "Disease":"Glioma",
    "Disease_Stage":"Progression",
    "Critical_Works_ID":"NCT01849952"
  },
  "miR-21": {
    "Type":"microRNA",
    "Names": [
        "microRNA 21"
    ],
    "Drug_Name(if_FDA_Approved)":"",
    "State_Change":"Normal",
    "Disease":"Colorectal Cancer",
    "Disease_Stage":"Early Detection and Prognosis",
    "Critical_Works_ID":"PMC3687369"
  },
  "EGFR": {
    "Type":"Protein",
    "Names": [
        "Epidermal Growth Factor Receptor",
        "ERB2"
    ],
    "Drug_Name(if_FDA_Approved)":"Afatinib",
    "State_Change":"EGFR exon 19 deletion or exon 21 substitution (L858R) positive",
    "Disease":"Non-Small Cell Lung Cancer",
    "Disease_Stage":"Progression",
    "Critical_Works_ID":"UCM360574"
  },
  "CA125": {
    "Type":"Protein",
    "Names": [
        "Cancer Antigen 125"
    ],
    "Drug_Name(if_FDA_Approved)":"",
    "State_Change":"Normal",
    "Disease":"Ovarian Cancer",
    "Disease_Stage":"Prognosis, Diagnosis, Therapy",
    "Critical_Works_ID":"PMC4046138"
  },
  "ALCAM": {
    "Type":"Protein",
    "Names": [
        "Activated Leukocyte Cell Adhesion Molecule"
    ],
    "Drug_Name(if_FDA_Approved)":"",
    "State_Change":"Normal",
    "Disease":"Breast Cancer",
    "Disease_Stage":"Screening, Diagnosis",
    "Critical_Works_ID":"PMC3743675"
  },
  "CTAP III": {
    "Type":"Protein",
    "Names": [
        "Connective tissue-activating peptide III"
    ],
    "Drug_Name(if_FDA_Approved)":"",
    "State_Change":"Normal",
    "Disease":"Lung Cancer",
    "Disease_Stage":"Early Detection",
    "Critical_Works_ID":"PMC2698017"
  },
  "COX-2": {
    "Type":"Protein (enzyme)",
    "Names": [
        "Cyclooxygenase-2"
    ],
    "Drug_Name(if_FDA_Approved)":"",
    "State_Change":"Normal",
    "Disease":"Hypopharyngeal squamous cell carcinomas",
    "Disease_Stage":"Prognosis, Early Detection",
    "Critical_Works_ID":"PMC3760833"
  },
  "miR-155": {
    "Type":"microRNA",
    "Names": [
        "microRNA 155"
    ],
    "Drug_Name(if_FDA_Approved)":"",
    "State_Change":"Normal",
    "Disease":"Esophageal Cancer",
    "Disease_Stage":"Early Diagnosis/Detection",
    "Critical_Works_ID":"22891887"
  },
  "CA 15-3": {
    "Type":"Glycoprotein",
    "Names": [
        "Cancer Antigen 15-3"
    ],
    "Drug_Name(if_FDA_Approved)":"",
    "State_Change":"Normal",
    "Disease":"Breast Cancer",
    "Disease_Stage":"Prognosis",
    "Critical_Works_ID":"11192829"
  },
  "18F-FDG": {
    "Type":"Imaging Biomarker",
    "Names": [
        "2-deoxy-2-[fluorine-18]fluoro- D-glucose"
    ],
    "Drug_Name(if_FDA_Approved)":"Fludeoxyglucose",
    "State_Change":"n/a",
    "Disease":"All",
    "Disease_Stage":"Diagnosis, Staging",
    "Critical_Works_ID":"PMC3101722"
  }
}